Suppr超能文献

遗传性甲基丙二酸血症的自然病史。

The natural history of the inherited methylmalonic acidemias.

作者信息

Matsui S M, Mahoney M J, Rosenberg L E

出版信息

N Engl J Med. 1983 Apr 14;308(15):857-61. doi: 10.1056/NEJM198304143081501.

Abstract

Six biochemical and genetic forms of methylmalonic acidemia have been defined previously: two (mut degrees and mut-) resulting from defects in the mutase apoenzyme, and four (cbl A, cbl B, cbl C, and cbl D) resulting from deficient adenosylcobalamin synthesis. We retrospectively surveyed the clinical presentation, response to cobalamin supplementation, and long-term outcome in the four most prevalent mutant classes by collecting detailed information on 45 patients (15 mut degrees, 5 mut-, 14 cbl A, and 11 cbl B). Most patients presented acutely with a common set of clinical and laboratory findings; however, there were significant differences between mutant classes: mut degrees patients presented earlier in infancy than did cbl A and cbl B patients; in response to cobalamin supplements, marked decreases in the concentration of methylmalonic acid in blood or urine were reported in most cbl A patients and in nearly half the cbl B patients, but not in mut degrees or mut- patients; and finally, most cbl A, cbl B, and mut- patients were still living, whereas most mut degrees patients died during the first few months of life. Our data indicate that genotypic classification of the methylmalonic acidemias has prognostic and therapeutic use as well as diagnostic value.

摘要

甲基丙二酸血症先前已被定义为六种生化和遗传形式

两种(mut°和mut-)是由于变位酶脱辅基酶缺陷导致的,四种(cbl A、cbl B、cbl C和cbl D)是由于腺苷钴胺素合成不足导致的。我们通过收集45例患者(15例mut°、5例mut-、14例cbl A和11例cbl B)的详细信息,对四种最常见突变类型的临床表现、钴胺素补充反应及长期预后进行了回顾性研究。大多数患者急性起病,具有一组常见的临床和实验室检查结果;然而,不同突变类型之间存在显著差异:mut°患者比cbl A和cbl B患者在婴儿期发病更早;在钴胺素补充治疗后,大多数cbl A患者以及近一半的cbl B患者血液或尿液中的甲基丙二酸浓度显著降低,但mut°和mut-患者未见降低;最后,大多数cbl A、cbl B和mut-患者仍然存活,而大多数mut°患者在生命的最初几个月内死亡。我们的数据表明,甲基丙二酸血症的基因型分类具有预后、治疗及诊断价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验